A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy-Reference-Cited by-同舟云学术

A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

Published:2021-12 Issue:12 Volume:120 Page:2176-2185
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Lee I-Han^ORCID,Chen Guann-Yiing,Chien Chun-Ru,Cheng Jason Chia-Hsien,Chen Jenny Ling-Yu,Yang Wen-Chi,Chen Jin-Shing,Hsu Feng-Ming^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

3. A prospective, molecular epidemiology study of EGFR mutations in asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER);Shi;J Thorac Oncol,2014

4. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function;Choi;Ann Oncol,2017

5. Reduced lung-cancer mortality with low-dose computed tomographic screening;Team;N Engl J Med,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical early‐stage non‐small‐cell lung cancer: a population‐based study;Thoracic Cancer;2024-07-16

2. Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan;Thoracic Cancer;2023-01-18

3. Highlights;Journal of the Formosan Medical Association;2021-12